21 October 2022 in Korean Journal of Otorhinolaryngology-Head and Neck Surgery
Background and Objectives A large-scale community-based study of the general population has not been conducted. There have been no studies on the relationship between decreased renal function and the degree of hearing loss. Thus, the purpose was to evaluate the relationship between hearing loss and impaired renal function with a large number of populations.Subjects and Method We performed a cross-sectional population-based cohort study by enrolling 470718 adults, 18 to 80 years old with pure tone audiometry tests who had regular health screening between 2013 and 2018. Hearing loss was defined as a pure-tone average of thresholds at 500, 1000, and 2000 Hz in both right and left ears. Kidney function was evaluated based on eGFR. Chronic kidney disease (CKD) was diagnosed as an eGFR25 dB) and 5.0% had above moderate hearing loss (>40 dB). But those with normal kidney function, 2.0% either had any hearing loss and 0.4% had above moderate hearing loss. The odds ratio (OR) of above moderate hearing loss for participants with CKD was 1.51 (95% confidence interval [CI]: 1.15-2.00, p=0.003) but the OR of mild hearing loss for participants with CKD was 0.82 (95% CI: 0.67- 1.02, p=0.073). The result suggested that CKD and above moderate hearing loss were related even after correcting for potential confounders, but had no statistical significance with mild hearing loss.Conclusion Decreased kidney function is associated with above moderate hearing loss.
21 June 2021 in Korean Journal of Otorhinolaryngology-Head and Neck Surgery
Parotid mass with facial palsy is often suggestive of malignancy. Facial palsy is present in 12% to 19% of patients with a malignant parotid mass regardless of tumor size. Xanthogranulomatous sialadenitis is a rare chronic inflammatory disorder. This is characterized by suppurative granulomatous inflammation and progressive destruction of the normal parenchyma. Since its first report in 1993, xanthogranulomatous sialadenitis has been reported in no more than 10 reports abroad, and to our knowledge, it has never been reported in Korea. It is hard to distinguish clinically xanthogranulomatous sialadenitis from malignancy because they have similar clinical symptoms and radiologic findings, so they should be diagnosed with pathologic methods. With a review of literature, the authors report a case of a parotid mass considered malignant in a 62-year-old, who has complained of a painful right parotid mass and ipsilateral facial palsy. The patient was managed by superficial parotidectomy and conservative antibitoic therapy.
15 June 2024 in Research in Vestibular Science
Objectives: This study is performed to evaluate the effect of early steroid treatment within 24 hours of onset in acute vestibular neuritis (AVN).Methods: We performed a retrospective case-control study with 46 patients with AVN. Video head impulse test paradigm (HIMP) and suppression HIMP were performed, and dizziness handicap index (DHI) was determined at initial; all tests were repeated at 1 month. Patients were divided into two groups depending on whether they were treated with steroids (group S, n=21) or not (group n-S, n=25).Results: There was no significant difference in age, sex, and side between the two groups. In HIMP, group S showed a significantly lower occurrence of overt corrective saccade (CS) (p=0.034) and lower peak velocity of overt CS (p=0.020) than group n-S at 1 month. In addition, the DHI score at 1 month was significantly lower in group S than in group n-S (p=0.040). In correlation analysis between subjective symptom and objective parameters, the DHI score showed a significant correlation with the occurrence of overt CS (p=0.028) and PR score (p=0.006) at 1 month.Conclusions: Early steroid treatment in AVN would be helpful for relieving symptoms and the improvement of vestibular ocular reflex function in the recovery phase.